Last reviewed · How we verify
Fentanyl and Midazolam infusion
At a glance
| Generic name | Fentanyl and Midazolam infusion |
|---|---|
| Sponsor | Clínica de Los Andes IPS |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy (PHASE3)
- General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound (NA)
- Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients (NA)
- Electrophysiologist-led Deep Sedation Protocols for Pulsed Field Ablation for Atrial Fibrillation Using a Bipolar Tip-Catheter: The DEEP-PFA Randomized Controlled Trial (NA)
- Effect of Dexmedetomidine on Tear Production in Angioplasty Patients (NA)
- Comparison of the Effects of Target-Controlled Infusion Method and Manual Propofol Administration on Respiratory Function, Recovery, and Electroencephalogram in Endoscopic Submucosal Dissection Cases (NA)
- Adjuvant Continuous Infusion of Nefopam Versus Standard of Care in Mechanically Ventilated Critically Ill Patients: Randomized Double-blind Controlled Study (PHASE3)
- Safety of Driving After Minor Surgery With Monitored Anesthesia Care (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fentanyl and Midazolam infusion CI brief — competitive landscape report
- Fentanyl and Midazolam infusion updates RSS · CI watch RSS
- Clínica de Los Andes IPS portfolio CI